Gainers
- Infinity Pharmaceuticals INFI stock moved upwards by 60.9% to $0.14 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 108.7 million, which is 11458.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.9 million.
- Vivos Therapeutics VVOS shares moved upwards by 59.0% to $0.41. The current volume of 64.5 million shares is 19105.0% of Vivos Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $12.4 million.
- Cardiff Oncology CRDF stock rose 35.03% to $2.12. Trading volume for Cardiff Oncology's stock is 8.4 million as of 13:30 EST. This is 5382.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $94.7 million.
- Fresh2 Group FRES stock rose 28.12% to $3.23. The market value of their outstanding shares is at $20.2 million.
- Tilray Brands TLRY stock moved upwards by 27.59% to $2.83. Trading volume for this security as of 13:30 EST is 87.4 million, which is 444.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.9 billion.
- electroCore ECOR shares moved upwards by 22.75% to $6.15. The current volume of 105.1K shares is 377.1% of electroCore's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $29.2 million.
Losers
- Vistagen Therapeutics VTGN stock fell 37.7% to $8.13 during Tuesday's regular session. As of 13:30 EST, Vistagen Therapeutics's stock is trading at a volume of 7.5 million, which is 712.3% of its average full-day volume over the last 100 days. The company's market cap stands at $64.9 million.
- Mallinckrodt MNK shares fell 21.83% to $1.42. The current volume of 7.7 million shares is 165.8% of Mallinckrodt's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $18.6 million.
- Tempest Therapeutics TPST stock declined by 19.42% to $0.69. As of 13:30 EST, Tempest Therapeutics's stock is trading at a volume of 1.2 million, which is 1747.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.9 million.
- Arcturus Therapeutics ARCT shares decreased by 19.25% to $25.72. The current volume of 775.0K shares is 179.2% of Arcturus Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $683.1 million. As per the news, the Q2 earnings report came out yesterday.
- Axogen AXGN shares declined by 18.79% to $6.72. As of 13:30 EST, this security is trading at a volume of 2.9 million shares, making up 1609.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $288.6 million. As per the press release, Q2 earnings came out yesterday.
- FibroGen FGEN shares declined by 18.65% to $1.44. The current volume of 5.3 million shares is 191.5% of FibroGen's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $140.5 million. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in